Nifty
Sensex
:
:
25637.80
84058.90
88.80 (0.35%)
303.03 (0.36%)

Pharmaceuticals & Drugs - Global

Rating :
51/99

BSE: 506690 | NSE: UNICHEMLAB

591.90
27-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  600
  •  603.25
  •  589.25
  •  599.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  32424
  •  19320030.4
  •  937.95
  •  511.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,171.89
  • 30.34
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,484.23
  • N/A
  • 1.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.22%
  • 0.36%
  • 14.80%
  • FII
  • DII
  • Others
  • 0.98%
  • 10.11%
  • 3.53%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.56
  • 9.09
  • 10.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.08
  • -
  • 6.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.93
  • 18.48

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.31
  • 1.15
  • 1.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.38
  • 23.19
  • 21.40

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
-10.01
19.53
P/E Ratio
-59.13
30.31
Revenue
1657
2111
EBITDA
100
265
Net Income
-70
138
ROA
-2.2
4.1
P/B Ratio
1.82
1.70
ROE
-2.94
5.71
FCFF
-28
-162
FCFF Yield
-0.6
-3.51
Net Debt
107
342
BVPS
325.91
348.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
587.18
459.60
27.76%
533.09
465.72
14.47%
462.16
415.63
11.20%
446.43
423.19
5.49%
Expenses
503.48
437.97
14.96%
447.57
434.60
2.98%
404.63
406.86
-0.55%
402.94
395.17
1.97%
EBITDA
83.70
21.63
286.96%
85.52
31.12
174.81%
57.53
8.77
555.99%
43.50
28.02
55.25%
EBIDTM
14.25%
4.71%
16.04%
6.68%
12.45%
2.11%
9.74%
6.62%
Other Income
9.25
6.15
50.41%
13.62
11.27
20.85%
8.79
5.53
58.95%
3.86
8.63
-55.27%
Interest
5.46
4.59
18.95%
6.75
5.58
20.97%
4.79
6.73
-28.83%
4.03
5.76
-30.03%
Depreciation
29.69
30.88
-3.85%
30.54
31.62
-3.42%
28.54
29.45
-3.09%
28.33
28.77
-1.53%
PBT
57.80
-133.31
-
61.85
73.20
-15.51%
32.99
-21.88
-
15.00
2.12
607.55%
Tax
4.83
3.43
40.82%
4.00
-0.02
-
2.50
2.61
-4.21%
5.74
2.79
105.73%
PAT
52.97
-136.74
-
57.85
73.22
-20.99%
30.49
-24.49
-
9.25
-0.67
-
PATM
9.02%
-29.75%
10.85%
15.72%
6.60%
-5.89%
2.07%
-0.16%
EPS
7.52
-19.42
-
8.22
10.40
-20.96%
4.33
-3.48
-
1.31
-0.09
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
2,028.86
1,704.89
1,343.02
1,269.83
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
Net Sales Growth
15.01%
26.94%
5.76%
2.81%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
 
Cost Of Goods Sold
791.15
565.63
482.45
356.91
302.14
308.63
364.19
274.97
188.77
386.97
378.57
Gross Profit
1,237.71
1,139.27
860.57
912.92
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
GP Margin
61.01%
66.82%
64.08%
71.89%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
Total Expenditure
1,758.62
1,604.65
1,388.58
1,197.04
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
Power & Fuel Cost
-
107.14
102.84
78.05
68.89
73.02
76.39
49.23
41.62
38.25
39.39
% Of Sales
-
6.28%
7.66%
6.15%
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
Employee Cost
-
393.06
356.41
330.49
306.97
273.28
238.52
200.64
169.04
255.92
223.20
% Of Sales
-
23.05%
26.54%
26.03%
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
Manufacturing Exp.
-
227.80
194.60
193.21
215.73
232.08
147.23
125.30
103.70
150.54
145.03
% Of Sales
-
13.36%
14.49%
15.22%
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
General & Admin Exp.
-
133.02
119.02
109.60
123.98
147.90
229.37
594.53
744.66
167.66
153.29
% Of Sales
-
7.80%
8.86%
8.63%
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
Selling & Distn. Exp.
-
178.00
129.56
120.68
122.52
116.12
197.24
108.38
107.77
166.84
157.12
% Of Sales
-
10.44%
9.65%
9.50%
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
Miscellaneous Exp.
-
0.00
3.70
8.11
3.81
3.50
16.26
5.16
2.06
2.58
157.12
% Of Sales
-
0%
0.28%
0.64%
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
EBITDA
270.25
100.24
-45.56
72.79
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
EBITDA Margin
13.32%
5.88%
-3.39%
5.73%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
Other Income
35.52
31.60
38.52
47.51
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
Interest
21.03
22.66
17.31
6.11
5.12
7.85
7.52
8.01
3.36
2.90
3.04
Depreciation
117.10
113.24
113.44
91.17
84.36
81.67
67.37
50.51
43.52
38.79
41.27
PBT
167.64
-4.06
-137.80
23.03
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
Tax
17.07
8.81
25.86
-11.09
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
Tax Rate
10.18%
-14.29%
-14.66%
-48.15%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
PAT
150.56
-70.47
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
PAT before Minority Interest
150.56
-70.47
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.42%
-4.13%
-15.06%
2.60%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
PAT Growth
269.78%
-
-
-4.64%
-
-
-
2,245.96%
0.01%
44.10%
 
EPS
21.39
-10.01
-28.73
4.70
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,362.42
2,435.30
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
Share Capital
14.08
14.08
14.08
14.08
14.08
14.08
14.07
18.18
18.17
18.15
Total Reserves
2,345.27
2,409.18
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
Non-Current Liabilities
92.27
108.03
143.88
49.16
43.72
10.10
46.46
64.49
76.02
74.21
Secured Loans
38.22
63.65
89.01
0.00
0.00
0.00
0.33
0.44
22.98
20.35
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
35.80
41.91
39.96
30.41
23.51
14.60
10.76
25.33
12.58
8.88
Current Liabilities
707.88
639.60
552.13
505.76
566.73
502.92
463.51
392.62
275.09
211.76
Trade Payables
299.37
290.69
183.19
210.08
250.22
221.41
226.23
210.73
163.95
138.23
Other Current Liabilities
115.19
128.34
135.06
176.97
122.04
68.45
63.03
68.01
60.56
45.86
Short Term Borrowings
155.26
208.08
215.69
100.63
184.03
199.67
150.29
97.62
12.93
1.63
Short Term Provisions
138.06
12.50
18.19
18.09
10.44
13.39
23.97
16.25
37.65
26.05
Total Liabilities
3,162.57
3,182.93
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
Net Block
1,195.97
1,256.66
990.03
880.42
866.06
806.29
574.45
487.22
402.60
415.99
Gross Block
1,793.08
1,750.29
1,379.74
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
Accumulated Depreciation
597.10
493.63
389.70
313.14
232.21
169.67
115.29
74.15
36.92
308.66
Non Current Assets
1,465.06
1,591.06
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
Capital Work in Progress
122.71
147.45
493.81
567.50
330.47
92.39
238.15
249.98
237.13
122.64
Non Current Investment
0.02
0.16
0.28
159.12
134.38
129.20
9.20
9.51
5.54
5.83
Long Term Loans & Adv.
124.91
168.07
165.59
112.89
112.90
56.37
24.05
25.57
28.05
44.61
Other Non Current Assets
21.45
18.72
16.30
14.52
11.52
9.39
7.74
0.00
0.00
0.00
Current Assets
1,694.16
1,588.47
1,644.92
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
Current Investments
1.34
1.54
263.58
236.43
419.10
800.75
895.55
8.00
8.04
35.04
Inventories
704.68
625.23
600.22
538.34
396.54
338.66
272.86
281.71
230.57
207.68
Sundry Debtors
610.40
588.62
495.43
250.27
390.14
436.05
276.92
315.32
220.09
191.58
Cash & Bank
154.32
185.36
114.10
82.45
233.81
200.99
681.46
16.14
20.13
26.96
Other Current Assets
223.42
31.31
34.60
62.21
246.88
262.83
209.68
127.29
153.28
103.17
Short Term Loans & Adv.
194.09
156.40
136.99
207.62
183.04
194.18
145.51
98.80
122.77
82.25
Net Current Assets
986.28
948.86
1,092.80
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
Total Assets
3,159.22
3,179.53
3,310.94
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
16.69
-85.09
-259.61
32.98
19.82
-327.77
-112.34
68.19
111.91
78.10
PBT
-61.67
-176.36
21.97
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
Adjustment
187.39
132.84
80.46
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
Changes in Working Capital
-102.65
-29.36
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
Cash after chg. in Working capital
23.07
-72.88
-252.00
47.35
24.15
-315.57
-113.20
95.91
143.16
96.49
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.38
-12.21
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
50.40
202.81
102.40
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
Net Fixed Assets
-1.95
-20.93
-121.73
-327.70
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
Net Investments
-3.55
349.28
134.15
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
Others
55.90
-125.54
89.98
106.22
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
Cash from Financing Activity
-106.31
-81.30
191.23
-121.07
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
Net Cash Inflow / Outflow
-39.21
36.42
34.01
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
Opening Cash & Equivalents
183.75
109.20
77.46
231.52
197.05
666.07
11.21
11.67
26.96
52.15
Closing Cash & Equivalent
150.91
183.75
109.20
77.46
231.52
197.05
666.07
11.21
20.13
26.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
335.11
344.18
370.38
362.05
358.85
371.69
380.95
116.88
104.93
95.48
ROA
-2.22%
-6.22%
1.03%
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
ROE
-2.95%
-8.04%
1.28%
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
ROCE
-1.47%
-5.60%
1.00%
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
Fixed Asset Turnover
0.96
0.86
0.99
1.08
1.06
1.43
2.21
3.08
2.32
1.71
Receivable days
128.35
147.31
107.17
94.63
136.61
109.51
78.30
63.41
55.72
58.55
Inventory Days
142.36
166.52
163.63
138.14
121.57
93.93
73.33
60.67
59.32
62.03
Payable days
190.38
179.25
201.09
278.03
76.39
73.41
94.97
104.25
52.00
52.61
Cash Conversion Cycle
80.33
134.58
69.71
-45.27
181.78
130.03
56.65
19.82
63.05
67.97
Total Debt/Equity
0.09
0.12
0.13
0.04
0.07
0.08
0.06
0.09
0.04
0.03
Interest Cover
-1.72
-9.19
4.60
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45

News Update:


  • USFDA conducts inspection at Unichem Laboratories’ Roha API facility
    23rd Jun 2025, 09:50 AM

    The inspection closed with three observations which were more of procedural changes with none of these related to data integrity

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.